metronidazole has been researched along with Dyspepsia in 151 studies
Metronidazole: A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS.
metronidazole : A member of the class of imidazoles substituted at C-1, -2 and -5 with 2-hydroxyethyl, nitro and methyl groups respectively. It has activity against anaerobic bacteria and protozoa, and has a radiosensitising effect on hypoxic tumour cells. It may be given by mouth in tablets, or as the benzoate in an oral suspension. The hydrochloride salt can be used in intravenous infusions. Metronidazole is a prodrug and is selective for anaerobic bacteria due to their ability to intracellularly reduce the nitro group of metronidazole to give nitroso-containing intermediates. These can covalently bind to DNA, disrupting its helical structure, inducing DNA strand breaks and inhibiting bacterial nucleic acid synthesis, ultimately resulting in bacterial cell death.
Dyspepsia: Impaired digestion, especially after eating.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Helicobacter pylori-positive patients (n=323) with non-ulcer dyspepsia were randomized to receive one of four 1-week regimens consisting of omeprazole, 20 mg b." | 9.09 | A randomized comparison of four omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. ( Barthélemy, P; Caekaert, A; Fléjou, JF; Laurent, J; Mégraud, F, 2001) |
| "A total of 59 consecutive Helicobacter pylori infected non-ulcer dyspepsia patients were randomly selected to receive either one of two triple therapy regimens, including metronidazole, amoxycillin plus ranitidine bismuth citrate (RAM group) or omeprazole (OAM group)." | 9.09 | Ranitidine bismuth citrate or omeprazole-based triple therapy for Helicobacter pylori eradication in Helicobacter pylori-infected non-ulcer dyspepsia. ( Chuang, CH; Lin, XZ; Sheu, BS; Wu, JJ; Yang, HB, 2001) |
| " pylori-positive patients with non-ulcer dyspepsia were randomized into one of two regimens: (i) bismuth subsalicylate 300 mg q." | 5.12 | The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori. ( Bagci, S; Ilgan, S; Kadayifci, A; Safali, M; Uygun, A, 2007) |
| "Adult Helicobacter pylori-positive patients by 13C-urea breath test with uninvestigated dyspepsia symptoms were randomized to 1-week eradication treatment with omeprazole, metronidazole and clarithromycin (OMC) vs." | 5.11 | Economic evaluation of Helicobacter pylori eradication in the CADET-Hp randomized controlled trial of H. pylori-positive primary care patients with uninvestigated dyspepsia. ( Armstrong, D; Barkun, A; Chiba, N; Escobedo, S; Grace, E; Lee, J; Sinclair, P; Thomson, AB; Veldhuyzen Van Zanten, SJ, 2004) |
| " pylori positive patients with non-ulcer dyspepsia were randomised to one of the following four treatment groups: omeprazole 20 mg + clarithromycin 500 mg + amoxycillin 1000 mg (OCA); ranitidine bismuth citrate 400 mg + clarithromycin 500 mg + amoxycillin 1000 mg (RBCCA); omeprazole 20 mg + clarithromycin 500 mg + metronidazole 500 mg (OCM); ranitidine bismuth citrate 400 mg + clarithromycin 500 mg + metronidazole 500 mg (RBCCM)." | 5.10 | The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial. ( Bago, J; Bevanda, M; Bilić, A; Halle, ZB; Jandrić, D; Kućisec, N; Strinić, D; Tomić, M, 2002) |
| "We used data from a randomized placebo-controlled clinical trial to examine the relationship between Helicobacter pylori and reflux symptoms in nonulcer dyspepsia patients randomly assigned anti-Helicobacter pylori triple therapy alone, calcium carbonate alone, or in combination with triple therapy, tetracycline, or placebo." | 5.10 | Increased reflux symptoms after calcium carbonate supplementation and successful anti-Helicobacter pylori treatment. ( Correa, P; Feldman, M; Fischbach, LA; Fontham, E; Goodman, KJ; Jain, R; Priest, E, 2003) |
| "A total of 59 consecutive Helicobacter pylori infected non-ulcer dyspepsia patients were randomly selected to receive either one of two triple therapy regimens, including metronidazole, amoxycillin plus ranitidine bismuth citrate (RAM group) or omeprazole (OAM group)." | 5.09 | Ranitidine bismuth citrate or omeprazole-based triple therapy for Helicobacter pylori eradication in Helicobacter pylori-infected non-ulcer dyspepsia. ( Chuang, CH; Lin, XZ; Sheu, BS; Wu, JJ; Yang, HB, 2001) |
| " pylori-positive patients with endoscopically defined peptic ulcer [DU (n = 65), GU (n = 12)] or non-ulcer dyspepsia (NUD, n = 43) were randomized to receive a 1-week course of twice daily omeprazole 20 mg, clarithromycin 250 mg and either metronidazole 400 mg (OCM) or tinidazole 500 mg (OCT) in a double-blind fashion." | 5.09 | Randomized controlled comparison of nitroimidazoles for the eradication of Helicobacter pylori and relief of ulcer-associated and non-ulcer dyspepsia. ( Goddard, AF; Lawes, S; Logan, RP; Spiller, RC, 1999) |
| "Non-ulcer dyspepsia patients (n=199), with a normal upper endoscopy and a positive (13)C-urea breath test (UBT) were randomly assigned to either pantoprazole, clarithromycin and metronidazole (PCM) or pantoprazole, clarithromycin and eicosapen (PCE) for 7 days." | 5.09 | Fish oil (Eicosapen) is less effective than metronidazole, in combination with pantoprazole and clarithromycin, for Helicobacter pylori eradication. ( Drewe, J; Geiser, HR; Meier, R; Wettstein, A, 2001) |
| "Helicobacter pylori-positive patients (n=323) with non-ulcer dyspepsia were randomized to receive one of four 1-week regimens consisting of omeprazole, 20 mg b." | 5.09 | A randomized comparison of four omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. ( Barthélemy, P; Caekaert, A; Fléjou, JF; Laurent, J; Mégraud, F, 2001) |
| "We performed a randomized, placebo-controlled trial comparing the efficacy of treatment for two weeks with 20 mg of omeprazole orally twice daily, 500 mg of amoxicillin three times daily (with 500 mg of tetracycline three times daily substituted for amoxicillin in patients allergic to penicillin), and 400 mg of metronidazole three times daily (160 patients) with that of omeprazole alone (158 patients) for resolving symptoms of dyspepsia in patients with H." | 5.08 | Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. ( Dickson, A; El-Nujumi, A; El-Omar, E; Hilditch, T; Kelman, A; Knill-Jones, R; McColl, K; Murray, L; Penny, C; Wirz, A, 1998) |
| "In an open study 66 consecutive infected patients with ulcer disease or non-ulcer dyspepsia were treated with 4-day quadruple therapy after 3 days of lansoprazole pretreatment." | 5.08 | Four-day lansoprazole-quadruple therapy in the routine treatment of Helicobacter pylori infection. ( de Boer, WA; Schneeberger, PM; van Etten, RJ, 1998) |
| "The aim of this study was to assess the effect of colloidal bismuth subcitrate (CBS) and metronidazole on Helicobacter pylori eradication and on the course of symptoms due to functional dyspepsia." | 5.08 | Eradication of Helicobacter pylori and long-term outcome of functional dyspepsia. A clinical endoscopic study. ( Bargiggia, S; Bianchi Porro, G; Boldorini, M; Lazzaroni, M; Maconi, G; Sangaletti, O, 1996) |
| "Patients with active HP infection and peptic ulcer, a history of peptic ulcer, or nonulcer dyspepsia were randomized to either lansoprazole 30 mg b." | 5.08 | Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial. ( Barnett, JL; Chey, WD; DelValle, J; Elta, GH; Fisher, L; Hasler, WL; Nostrant, T; Scheiman, JM, 1997) |
| "pylori positive (histology and/or culture) ulcer disease (n = 17; acute ulcer: n = 11) or functional dyspepsia (n = 13) were treated over one week with pantoprazole 40 mg bd, clarithromycin 250 mg bd and metronidazole 400 mg bd." | 5.08 | [Short-term triple therapy with pantoprazole, clarithromycin and metronidazole in eradication of Helicobacter pylori]. ( Becker, T; Börsch, G; Labenz, J; Peitz, U; Stolte, M; Tillenburg, B, 1995) |
| " pylori infection and peptic ulcer disease (n = 64) or functional dyspepsia (n = 16), with similar demographic and clinical characteristics, were treated for 1 week with either omeprazole 20 mg once in the morning and clarithromycin 250 mg and metronidazole 400 mg twice daily (OCM; n = 40) or with omeprazole 20 mg once in the morning and clarithromycin 250 mg and tetracycline 500 mg twice daily (OCT; n = 40)." | 5.08 | One-week low-dose triple therapy for the eradication of Helicobacter pylori infection. ( Becker, T; Börsch, G; Labenz, J; Rühl, GH; Sollböhmer, M; Stolte, M; Tillenburg, B, 1995) |
| " Forty-six consecutive patients (suffering from either peptic ulcer or non-ulcer dyspepsia) with helicobacter pylori infection were randomly allocated to one of the following two groups: group 1 (n = 23) 2 weeks of treatment with bismuth subcitrate tablets (120 mgx4) + amoxycillin capsules (500 mgx4) + metronidazole tablets (250 mgx4); group 2 (n = 23) 2 weeks of treatment with amoxycillin capsules (500 mgx4) + metronidazole tablets (250 mgx4)." | 5.07 | Evaluation of two therapeutic regimens for the treatment of Helicobacter pylori infection. ( Corinaldesi, R; De Giorgio, R; Gasperoni, S; Paparo, GF; Poli, L; Stanghellini, V; Tucci, A; Varoli, O, 1994) |
| " Sixty-six patients (with nonulcer dyspepsia, inactive ulcer, or active ulcer) were given lansoprazole (30 mg, h." | 3.69 | Endoscopic topical therapy for the treatment of Helicobacter pylori infection. ( Ishino, Y; Kihira, K; Kimura, K; Saifuku, K; Satoh, K; Takimoto, T; Taniguchi, Y; Yamamoto, H; Yoshida, Y, 1996) |
| "We have performed a retrospective study of 103 patients with either peptic ulcer or non-ulcer dyspepsia, infected with metronidazole-sensitive strains of Helicobacter pylori (H." | 3.68 | Does a previous course of tripotassium dicitrato bismuthate affect the subsequent chances of successful Helicobacter pylori eradication? ( Bell, GD; Burridge, SM; Gant, PW; Harrison, G; Jones, PH; Powell, K; Trowell, JE; Weil, J, 1992) |
| "Levodopa was prescribed for groups 1 and 3." | 2.72 | Does delayed gastric emptying shorten the H pylori eradication period? A double blind clinical trial. ( Alizadeh, M; Arj, A; Bagheri-Lankarani, K; Bahri-Najafi, R; Dehbashi, N; Emami, MH; Esmaeili, A; Fattahi, MR; Geramizadeh, B; Kaviani, MJ; Saberfiroozi, MM; Taghavi, AR, 2006) |
| "A urea breath test was performed 1-2 months after eradication." | 2.71 | Eradication rate of Helicobacter pylori in dyspeptic patients. ( Amini, M; Khedmat, H; Yari, F, 2005) |
| "Peptic ulcer was found in 6." | 2.71 | Does the 'test-and-treat' strategy work in primary health care for management of uninvestigated dyspepsia? A prospective two-year follow-up study of 1552 patients. ( Färkkilä, M; Sarna, S; Sipponen, P; Valtonen, V, 2004) |
| "Rabeprazole is a new proton pump inhibitor, which has been reported to induce a faster acid suppression than other drugs of the same category." | 2.71 | Comparable Helicobacter pylori eradication rates obtained with 4- and 7-day rabeprazole-based triple therapy: a preliminary study. ( Bilardi, C; Dulbecco, P; Gambaro, C; Iiritano, E; Mansia, C; Savarino, V; Usai, P; Vigneri, S; Zentilin, P, 2003) |
| "Helicobacter pylori gastritis is usually a lifelong disease which can cause different topographical inflammatory reactions and induce divergent effects on acid secretion in humans." | 2.70 | Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia. ( Färkkilä, M; Koskenpato, J; Sipponen, P, 2002) |
| "Pretreatment with omeprazole did not reduce the cure rate for this new quadruple therapy." | 2.69 | A new quadruple therapy for the eradication of Helicobacter pylori. Effect of pretreatment with omeprazole on the cure rate. ( Maeda, K; Nishimura, H; Oda, K; Ohkuma, K; Okabe, N; Okada, M; Oki, K; Seo, M; Shirotani, T, 1998) |
| "pylori functional dyspepsia is prevalent in people over 60 years old." | 2.69 | Helicobacter pylori-positive functional dyspepsia in elderly patients: comparison of two treatments. ( Bentivegna, C; Branciforte, G; Brogna, A; Catalano, F; Chodash, HB; Dawson, BK; Luca, S; Michalos, A; Terranova, R, 1999) |
| "After eradication, 51 out of 53 treated rosacea patients became Hp negative." | 2.69 | Helicobacter pylori and its eradication in rosacea. ( Bielański, W; Karczewska, E; Konturek, SJ; Pytko-Polonczyk, J; Sliwowski, Z; Szlachcic, A, 1999) |
| "Metronidazole resistance was induced in 8 out of 16 with a sensitive strain." | 2.68 | One-day intensified lansoprazole-quadruple therapy for cure of Helicobacter pylori infection. ( de Boer, WA; Ouwehand, ME; Schade, RW; Schneeberger, PM; Tytgat, GN; van Etten, RJ; van Unnik, AJ, 1997) |
| "Lansoprazole has superior anti-Helicobacter activity in vitro and possibly also in vivo; therefore we investigated quadruple therapy with lansoprazole." | 2.68 | Effectiveness of quadruple therapy using lansoprazole, instead of omeprazole, in curing Helicobacter pylori infection. ( de Boer, WA; Driessen, WM; Lai, JY; Schneeberger, PM; van de Wouw, BA; van Etten, RJ, 1996) |
| "Some recent studies have reported high recurrence rates after apparent cure." | 2.68 | Long-term follow-up after cure of Helicobacter pylori infection with 4 days of quadruple therapy. ( De Boer, WA; Driessen, WM; Geuskens, LM; Lai, JY, 1996) |
| "Treatment with bismuth subsalicylate and metronidazole resulted in symptomatic improvement in 61-66% of non-ulcer dyspepsia patients regardless of initial or post-treatment H." | 2.68 | Long-term follow-up of Helicobacter pylori treatment in non-ulcer dyspepsia patients. ( Appelman, HD; Barnett, JL; Behler, EM; Crause, I; Elta, GH; Nostrant, TT; Scheiman, JM, 1995) |
| "Omeprazole can enhance efficacy of single and double antibiotic protocols and is particularly effective when combined with clarithromycin and a nitroimidazole." | 2.68 | Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori. ( Andrews, P; Bae, H; Borody, TJ; Brandl, S; Fracchia, G; Shortis, NP, 1995) |
| "Dyspepsia was assessed on the frequency and severity of six symptoms [epigastric pain (night and day), nausea and vomiting, upper abdominal discomfort, and regurgitation] where each symptom was scored from 0 to 4." | 2.68 | Long-term prospective study of Helicobacter pylori in nonulcer dyspepsia. ( Beattie, S; Collins, RM; Keane, C; McCarthy, C; O'Morain, C; Patchett, S, 1995) |
| "All patients with peptic ulcer disease, gastric cancer, and MALT lymphoma should be tested for Hp." | 2.47 | Diagnosis and treatment of Helicobacter pylori infection. ( Bytzer, P; Dahlerup, JF; Eriksen, JR; Jarbøl, DE; Rosenstock, S; Wildt, S, 2011) |
| "The aetiology of dyspepsia is unknown in the majority of patients." | 2.43 | Role of Helicobacter pylori in functional dyspepsia. ( O'Morain, C, 2006) |
| "pylori infection decreases recurrence rates and facilitates healing, antibiotic therapy is indicated for all H." | 2.39 | Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology. ( Soll, AH, 1996) |
| "Levofloxacin resistance was significantly associated with the male sex (OR: 11." | 1.38 | High prevalence of primary antibiotic resistance in Helicobacter pylori isolates in Italy. ( Castelli, V; Fiorini, G; Gatta, L; Holton, J; Ricci, C; Ridola, L; Saracino, IM; Vaira, D; Zaccaro, C; Zullo, A, 2012) |
| "Metronidazole resistance was significantly more common in women (P < 0." | 1.32 | Helicobacter pylori: antibiotic resistance and eradication rates in Suffolk, UK, 1991-2001. ( Baldwin, L; Bell, GD; Cameron, EAB; Jones, P; Powell, KU; Williams, SGJ, 2004) |
| "Metronidazole resistance was determined by E-test after subculture." | 1.30 | Prevalence and demographic determinants of metronidazole resistance by Helicobacter pylori in a large cosmopolitan cohort of Australian dyspeptic patients. ( Bradbury, R; Katelaris, PH; Ngu, MC; Nguyen, TV; Robertson, GJ, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (1.32) | 18.7374 |
| 1990's | 64 (42.38) | 18.2507 |
| 2000's | 66 (43.71) | 29.6817 |
| 2010's | 17 (11.26) | 24.3611 |
| 2020's | 2 (1.32) | 2.80 |
| Authors | Studies |
|---|---|
| Valencia, ME | 1 |
| Montejano, R | 1 |
| Moreno, V | 1 |
| Martín Carbonero, L | 1 |
| Bernardino, JI | 1 |
| Serrano, L | 1 |
| Guevara, B | 1 |
| Cogdill, AG | 1 |
| Malfertheiner, P | 3 |
| Onal, IK | 1 |
| Gokcan, H | 1 |
| Benzer, E | 1 |
| Bilir, G | 1 |
| Oztas, E | 1 |
| Laving, A | 1 |
| Kamenwa, R | 1 |
| Sayed, S | 2 |
| Kimang'a, AN | 2 |
| Revathi, G | 2 |
| Hosseini, SM | 1 |
| Sharifipoor, F | 1 |
| Nazemian, F | 1 |
| Ghanei, H | 1 |
| Zivarifar, HR | 1 |
| Fakharian, T | 1 |
| Zagari, RM | 3 |
| Romano, M | 2 |
| Ojetti, V | 1 |
| Stockbrugger, R | 1 |
| Gullini, S | 1 |
| Annibale, B | 1 |
| Farinati, F | 1 |
| Ierardi, E | 1 |
| Maconi, G | 2 |
| Rugge, M | 2 |
| Calabrese, C | 1 |
| Di Mario, F | 2 |
| Luzza, F | 1 |
| Pretolani, S | 1 |
| Savio, A | 1 |
| Gasbarrini, G | 1 |
| Caselli, M | 1 |
| Di Giulio, M | 1 |
| Di Campli, E | 1 |
| Di Bartolomeo, S | 1 |
| Cataldi, V | 1 |
| Marzio, L | 1 |
| Grossi, L | 1 |
| Ciccaglione, AF | 1 |
| Nostro, A | 1 |
| Cellini, L | 1 |
| Tepeš, B | 1 |
| Vujasinović, M | 1 |
| Šeruga, M | 1 |
| Stefanovič, M | 1 |
| Forte, A | 1 |
| Jeverica, S | 1 |
| Campillo, A | 1 |
| Amorena, E | 1 |
| Ostiz, M | 1 |
| Kutz, M | 1 |
| LaIglesia, M | 1 |
| Georgopoulos, SD | 2 |
| Xirouchakis, E | 1 |
| Martinez-Gonzales, B | 1 |
| Zampeli, E | 1 |
| Grivas, E | 1 |
| Spiliadi, C | 2 |
| Sotiropoulou, M | 1 |
| Petraki, K | 1 |
| Zografos, K | 1 |
| Laoudi, F | 1 |
| Sgouras, D | 1 |
| Mentis, A | 2 |
| Kasapidis, P | 1 |
| Michopoulos, S | 1 |
| Chen, Q | 1 |
| Zhang, W | 1 |
| Fu, Q | 1 |
| Liang, X | 1 |
| Liu, W | 1 |
| Xiao, S | 1 |
| Lu, H | 1 |
| Geva, A | 1 |
| Sabo, E | 1 |
| Levy, J | 1 |
| Blumenthal, M | 1 |
| Ophir, E | 1 |
| Geva, H | 1 |
| Bornstein, J | 1 |
| Oyedeji, KS | 1 |
| Smith, SI | 1 |
| Coker, AO | 1 |
| Arigbabu, AO | 1 |
| Jakobsson, HE | 1 |
| Jernberg, C | 1 |
| Andersson, AF | 1 |
| Sjölund-Karlsson, M | 1 |
| Jansson, JK | 1 |
| Engstrand, L | 1 |
| Kariuki, S | 1 |
| Devani, S | 1 |
| Yakoob, J | 1 |
| Abid, S | 1 |
| Abbas, Z | 1 |
| Jafri, SN | 1 |
| Vilaichone, RK | 1 |
| Mahacahai, V | 1 |
| Tumwasorn, S | 1 |
| Kachintorn, U | 1 |
| Bytzer, P | 1 |
| Dahlerup, JF | 1 |
| Eriksen, JR | 1 |
| Jarbøl, DE | 1 |
| Rosenstock, S | 1 |
| Wildt, S | 1 |
| McNulty, CA | 1 |
| Lasseter, G | 1 |
| Shaw, I | 1 |
| Nichols, T | 1 |
| D'Arcy, S | 1 |
| Lawson, AJ | 1 |
| Glocker, E | 1 |
| Saracino, IM | 1 |
| Zullo, A | 1 |
| Holton, J | 1 |
| Castelli, V | 1 |
| Fiorini, G | 1 |
| Zaccaro, C | 1 |
| Ridola, L | 1 |
| Ricci, C | 1 |
| Gatta, L | 1 |
| Vaira, D | 1 |
| Boixeda, D | 1 |
| Bermejo, F | 1 |
| Martín-De-Argila, C | 1 |
| López-Sanromán, A | 1 |
| Defarges, V | 1 |
| Hernández-Ranz, F | 1 |
| Milicua, JM | 1 |
| García-Plaza, A | 1 |
| Koskenpato, J | 2 |
| Färkkilä, M | 3 |
| Sipponen, P | 3 |
| Rosandić, M | 1 |
| Pilas, V | 1 |
| Bevanda, M | 2 |
| Falisevac, V | 1 |
| Korać, B | 1 |
| McNamara, D | 1 |
| Buckley, M | 2 |
| Gilvarry, J | 2 |
| O'Morain, C | 4 |
| Bago, J | 1 |
| Halle, ZB | 1 |
| Strinić, D | 1 |
| Kućisec, N | 1 |
| Jandrić, D | 1 |
| Tomić, M | 1 |
| Bilić, A | 1 |
| Hung, WK | 1 |
| Wong, WM | 3 |
| Wong, GS | 1 |
| Yip, AW | 1 |
| Szeto, ML | 1 |
| Lai, KC | 4 |
| Hu, WH | 3 |
| Chan, CK | 3 |
| Xia, HH | 4 |
| Yuen, MF | 1 |
| Fung, FM | 2 |
| Tong, TS | 2 |
| Ho, VY | 2 |
| Lam, SK | 4 |
| Wong, BC | 4 |
| Murakami, K | 1 |
| Sato, R | 1 |
| Okimoto, T | 1 |
| Nasu, M | 1 |
| Fujioka, T | 1 |
| Kodama, M | 1 |
| Kagawa, J | 1 |
| Schuster, MJ | 1 |
| Toro, C | 1 |
| García-Samaniego, J | 1 |
| Alarcón, T | 1 |
| Baquero, M | 1 |
| Lau, CS | 1 |
| Ip, WY | 1 |
| Hui, WM | 1 |
| Wong, RW | 1 |
| Fischbach, LA | 1 |
| Correa, P | 1 |
| Feldman, M | 1 |
| Fontham, E | 1 |
| Priest, E | 1 |
| Goodman, KJ | 1 |
| Jain, R | 1 |
| Dore, MP | 2 |
| Marras, L | 1 |
| Maragkoudakis, E | 2 |
| Nieddu, S | 1 |
| Manca, A | 1 |
| Graham, DY | 1 |
| Realdi, G | 2 |
| Lara, LF | 1 |
| Cisneros, G | 1 |
| Gurney, M | 1 |
| Van Ness, M | 1 |
| Jarjoura, D | 1 |
| Moauro, B | 1 |
| Polen, A | 1 |
| Rutecki, G | 1 |
| Whittier, F | 1 |
| Lui, SY | 1 |
| Yeoh, KG | 1 |
| Ho, B | 1 |
| Gambaro, C | 1 |
| Bilardi, C | 1 |
| Dulbecco, P | 1 |
| Iiritano, E | 1 |
| Zentilin, P | 1 |
| Mansia, C | 1 |
| Usai, P | 1 |
| Vigneri, S | 1 |
| Savarino, V | 1 |
| Chiba, N | 2 |
| Veldhuyzen Van Zanten, SJ | 2 |
| Escobedo, S | 2 |
| Grace, E | 2 |
| Lee, J | 1 |
| Sinclair, P | 2 |
| Barkun, A | 1 |
| Armstrong, D | 2 |
| Thomson, AB | 1 |
| Marmo, R | 1 |
| Cuomo, A | 1 |
| De Simone, T | 1 |
| Mucherino, C | 1 |
| Iovene, MR | 1 |
| Montella, F | 1 |
| Tufano, MA | 1 |
| Del Vecchio Blanco, C | 1 |
| Nardone, G | 1 |
| Sarna, S | 1 |
| Valtonen, V | 1 |
| Cameron, EAB | 1 |
| Powell, KU | 3 |
| Baldwin, L | 1 |
| Jones, P | 1 |
| Bell, GD | 4 |
| Williams, SGJ | 1 |
| Gunaid, AA | 1 |
| Hassan, NA | 1 |
| Murray-Lyon, IM | 1 |
| Xiao, SD | 2 |
| Hu, PJ | 1 |
| Wang, WH | 1 |
| Gu, Q | 1 |
| Huang, JQ | 1 |
| Wu, SM | 1 |
| Li, CJ | 1 |
| Chen, MH | 1 |
| Cui, Y | 1 |
| Johansen, JK | 1 |
| Sehested, A | 1 |
| Myrhøj, T | 1 |
| Ladefoged, K | 1 |
| Krogfelt, KA | 1 |
| Amini, M | 1 |
| Khedmat, H | 1 |
| Yari, F | 1 |
| Elviss, NC | 1 |
| Owen, RJ | 2 |
| Breathnach, A | 1 |
| Palmer, C | 1 |
| Shetty, N | 1 |
| Huang, J | 1 |
| Cheung, KL | 1 |
| Chan, AO | 1 |
| Hui, CK | 1 |
| Zheng, Q | 1 |
| Pan, Y | 1 |
| Zhang, L | 1 |
| Pironti, A | 1 |
| Tadeu, V | 1 |
| Tedde, R | 1 |
| Delitala, G | 1 |
| Janssen, MJ | 1 |
| Hendrikse, L | 1 |
| de Boer, SY | 2 |
| Bosboom, R | 1 |
| de Boer, WA | 6 |
| Laheij, RJ | 1 |
| Jansen, JB | 1 |
| Sezgin, O | 1 |
| Altintaş, E | 1 |
| Uçbilek, E | 1 |
| Tataroğlu, C | 1 |
| Dzieniszewski, J | 1 |
| Jarosz, M | 1 |
| Emami, MH | 1 |
| Saberfiroozi, MM | 1 |
| Arj, A | 1 |
| Taghavi, AR | 1 |
| Bagheri-Lankarani, K | 1 |
| Dehbashi, N | 1 |
| Fattahi, MR | 1 |
| Alizadeh, M | 1 |
| Kaviani, MJ | 1 |
| Bahri-Najafi, R | 1 |
| Geramizadeh, B | 1 |
| Esmaeili, A | 1 |
| Latifi-Navid, S | 1 |
| Siavoshi, F | 1 |
| Safari, F | 1 |
| Malekzadeh, R | 2 |
| Massarrat, S | 2 |
| Kumala, W | 1 |
| Rani, A | 1 |
| Fallahi, GH | 1 |
| Maleknejad, S | 1 |
| Uygun, A | 3 |
| Ozel, AM | 1 |
| Yildiz, O | 1 |
| Aslan, M | 1 |
| Yesilova, Z | 2 |
| Erdil, A | 1 |
| Bagci, S | 2 |
| Gunhan, O | 1 |
| Chung, SJ | 1 |
| Lee, DH | 1 |
| Kim, N | 1 |
| Jung, SH | 1 |
| Kim, JW | 1 |
| Hwang, JH | 1 |
| Park, YS | 1 |
| Lee, KH | 1 |
| Jung, HC | 1 |
| Song, IS | 1 |
| Fuccio, L | 1 |
| Minardi, ME | 1 |
| Grilli, D | 1 |
| Magrini, N | 1 |
| Bazzoli, F | 2 |
| Kadayifci, A | 2 |
| Safali, M | 2 |
| Ilgan, S | 2 |
| Ndip, RN | 1 |
| Malange Takang, AE | 1 |
| Ojongokpoko, JE | 1 |
| Luma, HN | 1 |
| Malongue, A | 1 |
| Akoachere, JF | 1 |
| Ndip, LM | 1 |
| MacMillan, M | 1 |
| Weaver, LT | 1 |
| Karaeren, N | 1 |
| Hansen, JM | 1 |
| Wildner-Christensen, M | 1 |
| Hallas, J | 1 |
| Schaffalitzky de Muckadell, OB | 1 |
| Borody, TJ | 2 |
| Andrews, P | 1 |
| Fracchia, G | 1 |
| Brandl, S | 2 |
| Shortis, NP | 1 |
| Bae, H | 1 |
| Schepp, W | 1 |
| Hoffenberg, P | 1 |
| Reyes, V | 1 |
| Contreras, L | 1 |
| Giglio, M | 1 |
| Ossa, P | 1 |
| Weitz, JC | 1 |
| Blum, AL | 1 |
| Kreiss, C | 1 |
| Labenz, J | 3 |
| Peitz, U | 1 |
| Tillenburg, B | 2 |
| Becker, T | 2 |
| Börsch, G | 3 |
| Stolte, M | 2 |
| Elta, GH | 3 |
| Scheiman, JM | 2 |
| Barnett, JL | 3 |
| Nostrant, TT | 2 |
| Behler, EM | 2 |
| Crause, I | 1 |
| Appelman, HD | 1 |
| McCarthy, C | 1 |
| Patchett, S | 2 |
| Collins, RM | 1 |
| Beattie, S | 4 |
| Keane, C | 2 |
| Rühl, GH | 1 |
| Sollböhmer, M | 1 |
| Tucci, A | 1 |
| Poli, L | 1 |
| Gasperoni, S | 1 |
| Varoli, O | 1 |
| Paparo, GF | 1 |
| De Giorgio, R | 1 |
| Stanghellini, V | 1 |
| Corinaldesi, R | 1 |
| Thijs, JC | 1 |
| Van Zwet, AA | 1 |
| Oey, HB | 1 |
| Frazzoni, M | 1 |
| Lonardo, A | 1 |
| Grisendi, A | 1 |
| Della Casa, G | 1 |
| Pulvirenti, M | 1 |
| Ferrari, AM | 1 |
| Di Gregorio, C | 1 |
| Melini, L | 1 |
| Xia, HX | 3 |
| Daw, MA | 1 |
| Keane, CT | 3 |
| O'Morain, CA | 4 |
| Born, P | 1 |
| Götz, JM | 1 |
| Veenendaal, RA | 1 |
| Veselic, M | 1 |
| Bernards, S | 1 |
| Lamers, CB | 1 |
| Soll, AH | 1 |
| Dal Bó, N | 1 |
| Grassi, SA | 1 |
| Cassaro, M | 1 |
| Donisi, PM | 1 |
| Vianello, F | 1 |
| Kusstatscher, S | 1 |
| Salandin, S | 1 |
| Grasso, GA | 1 |
| Ferrana, M | 1 |
| Battaglia, G | 1 |
| Davis, S | 1 |
| Sheu, BS | 2 |
| Lin, CY | 1 |
| Lin, XZ | 2 |
| Shiesh, SC | 1 |
| Yang, HB | 2 |
| Chen, CY | 1 |
| Lazzaroni, M | 1 |
| Bargiggia, S | 1 |
| Sangaletti, O | 1 |
| Boldorini, M | 1 |
| Bianchi Porro, G | 1 |
| Driessen, WM | 3 |
| Tytgat, GN | 2 |
| Lai, JY | 2 |
| Geuskens, LM | 1 |
| Thor, P | 1 |
| Lorens, K | 1 |
| Tabor, S | 1 |
| Herman, R | 1 |
| Konturek, JW | 1 |
| Konturek, SJ | 2 |
| Kihira, K | 1 |
| Satoh, K | 1 |
| Saifuku, K | 1 |
| Taniguchi, Y | 1 |
| Takimoto, T | 1 |
| Yoshida, Y | 1 |
| Ishino, Y | 1 |
| Yamamoto, H | 1 |
| Kimura, K | 1 |
| Bock, H | 1 |
| Mares, A | 1 |
| van Etten, RJ | 3 |
| Schade, RW | 1 |
| Ouwehand, ME | 1 |
| Schneeberger, PM | 3 |
| van Unnik, AJ | 1 |
| Forbes, GM | 1 |
| Buckley, MJ | 2 |
| Hamilton, H | 1 |
| Chey, WD | 1 |
| Fisher, L | 1 |
| Nostrant, T | 1 |
| DelValle, J | 1 |
| Hasler, WL | 1 |
| Hyde, DM | 1 |
| Dobrucali, A | 1 |
| Tuncer, M | 1 |
| Eralp, YT | 1 |
| Goksel, S | 1 |
| Altin, M | 1 |
| Dinc, I | 1 |
| Adamek, RJ | 2 |
| Szymanski, C | 2 |
| Pfaffenbach, B | 2 |
| van de Wouw, BA | 1 |
| Bobrzyński, A | 1 |
| Gedliczka, O | 1 |
| Bielański, W | 2 |
| Stachura, J | 1 |
| Konturek, S | 1 |
| Budzyński, A | 1 |
| McColl, KE | 1 |
| el-Nujumi, A | 2 |
| Murray, LS | 1 |
| el-Omar, EM | 1 |
| Dickson, A | 2 |
| Kelman, AW | 1 |
| Hilditch, TE | 1 |
| Siem, TH | 1 |
| Okada, M | 1 |
| Oki, K | 1 |
| Shirotani, T | 1 |
| Seo, M | 1 |
| Okabe, N | 1 |
| Maeda, K | 1 |
| Nishimura, H | 1 |
| Ohkuma, K | 1 |
| Oda, K | 1 |
| Kalantar, J | 1 |
| Talley, NJ | 2 |
| Katelaris, PH | 1 |
| Nguyen, TV | 1 |
| Robertson, GJ | 1 |
| Bradbury, R | 1 |
| Ngu, MC | 1 |
| McColl, K | 1 |
| Murray, L | 1 |
| El-Omar, E | 1 |
| Wirz, A | 1 |
| Kelman, A | 1 |
| Penny, C | 1 |
| Knill-Jones, R | 1 |
| Hilditch, T | 1 |
| Lygren, I | 1 |
| Andersen, LP | 1 |
| Lerang, F | 1 |
| Kleveland, PM | 1 |
| Farup, P | 1 |
| Vatn, M | 1 |
| Aursnes, I | 1 |
| Goddard, AF | 1 |
| Logan, RP | 1 |
| Lawes, S | 1 |
| Spiller, RC | 2 |
| Catalano, F | 1 |
| Branciforte, G | 1 |
| Brogna, A | 1 |
| Bentivegna, C | 1 |
| Luca, S | 1 |
| Terranova, R | 1 |
| Michalos, A | 1 |
| Dawson, BK | 1 |
| Chodash, HB | 1 |
| Dhali, GK | 1 |
| Garg, PK | 1 |
| Sharma, MP | 1 |
| Sung, JJ | 1 |
| Chan, FK | 1 |
| Wu, JC | 1 |
| Leung, WK | 1 |
| Suen, R | 1 |
| Ling, TK | 1 |
| Lee, YT | 1 |
| Cheng, AF | 1 |
| Chung, SC | 1 |
| Zwimpfer, J | 1 |
| Adamsson, I | 1 |
| Nord, CE | 1 |
| Lundquist, P | 1 |
| Sjöstedt, S | 1 |
| Edlund, C | 1 |
| Szlachcic, A | 1 |
| Sliwowski, Z | 1 |
| Karczewska, E | 1 |
| Pytko-Polonczyk, J | 1 |
| Bojarski, C | 1 |
| Epple, HJ | 1 |
| Kirstein, FW | 1 |
| Fromm, M | 1 |
| Bisson, S | 1 |
| Riecken, EO | 1 |
| Schulzke, JD | 1 |
| Mendonça, S | 1 |
| Ecclissato, C | 1 |
| Sartori, MS | 1 |
| Godoy, AP | 1 |
| Guerzoni, RA | 1 |
| Degger, M | 1 |
| Pedrazzoli, J | 1 |
| Lawnik, M | 1 |
| Czkwianianc, E | 1 |
| Chmiela, M | 1 |
| Płaneta-Małecka, I | 1 |
| Rudnicka, W | 1 |
| Fakheri, H | 1 |
| Merat, S | 1 |
| Khatibian, M | 1 |
| Fazel, A | 1 |
| Alizadeh, BZ | 1 |
| Chuang, CH | 1 |
| Wu, JJ | 1 |
| Della Libera, E | 1 |
| Rohr, MR | 1 |
| Moraes, M | 1 |
| Siqueira, ES | 1 |
| Ferrari, AP | 1 |
| Meier, R | 1 |
| Wettstein, A | 1 |
| Drewe, J | 1 |
| Geiser, HR | 1 |
| Ferrus, M | 1 |
| Gibson, J | 1 |
| Hopkins, RJ | 1 |
| Moayyedi, P | 1 |
| Murphy, B | 1 |
| Nagahara, A | 1 |
| Miwa, H | 1 |
| Ohkura, R | 1 |
| Yamada, T | 1 |
| Sato, K | 1 |
| Hojo, M | 1 |
| Sato, N | 1 |
| Bardhan, KD | 1 |
| Morton, D | 1 |
| Perry, MJ | 1 |
| Sanders, DS | 1 |
| Morris, P | 1 |
| Rowland, A | 1 |
| Thompson, M | 1 |
| Mitchell, TR | 1 |
| Roberts, PM | 1 |
| Tankovic, J | 1 |
| Lamarque, D | 1 |
| Lascols, C | 1 |
| Soussy, CJ | 1 |
| Delchier, JC | 1 |
| Laurent, J | 1 |
| Mégraud, F | 1 |
| Fléjou, JF | 1 |
| Caekaert, A | 1 |
| Barthélemy, P | 1 |
| Gisbert, JP | 1 |
| Marcos, S | 1 |
| Gisbert, JL | 1 |
| Pajares, JM | 1 |
| Schilling, D | 1 |
| Messerer, P | 1 |
| Ott, MG | 1 |
| Schauwecker, P | 1 |
| Zober, A | 1 |
| Riemann, JF | 1 |
| Pozzato, P | 1 |
| Fossi, S | 1 |
| Ricciardiello, L | 1 |
| Nicolini, G | 1 |
| De Luca, L | 1 |
| Berretti, D | 1 |
| Alampi, G | 1 |
| Di Pietro, C | 1 |
| Morelli, P | 1 |
| Roda, E | 1 |
| Ladas, SD | 1 |
| Karatapanis, S | 1 |
| Triantafyllou, K | 1 |
| Artikis, V | 1 |
| Raptis, SA | 1 |
| Van Zanten, SJ | 1 |
| Ferguson, RA | 1 |
| Knippig, C | 1 |
| Arand, F | 1 |
| Leodolter, A | 1 |
| Nilius, M | 1 |
| Bayerdörffer, E | 1 |
| Klein, U | 1 |
| Katelaris, P | 1 |
| Adeyemi, EO | 1 |
| Fadlalla, H | 1 |
| al-Homsi, M | 1 |
| Nnalue, NA | 1 |
| Goodwin, S | 1 |
| Boehme, D | 1 |
| Sim, AJ | 1 |
| Burridge, SM | 2 |
| Spencer, G | 1 |
| Bolton, G | 1 |
| Purser, K | 1 |
| Brooks, S | 1 |
| Prosser, S | 1 |
| Harrison, G | 2 |
| Gant, PW | 2 |
| Smoot, DT | 1 |
| Scott, VF | 1 |
| Heatley, RV | 1 |
| Powell, K | 1 |
| Weil, J | 1 |
| Jones, PH | 1 |
| Trowell, JE | 1 |
| Laine, L | 1 |
| Leen, E | 1 |
| Ormand, JE | 1 |
| Carpenter, HA | 1 |
| Phillips, SF | 1 |
| Bhatia, RS | 1 |
| Nigam, P | 1 |
| Cole, P | 1 |
| Noonan, S | 1 |
| Morgan, A | 1 |
| Lenne, J | 1 |
| Hyland, L | 1 |
| Borody, EG | 1 |
| George, LL | 1 |
| Murphy, R | 1 |
| Kern, S | 1 |
| Appelman, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| 10 Day Concomitant Versus 14 Day Hybrid Regimen as First Line H. Pylori Eradication Treatment in a High Clarithromycin Resistance Area. A Multicenter Randomized Equivalence Trial[NCT03592069] | Phase 4 | 345 participants (Actual) | Interventional | 2018-02-21 | Completed | ||
| Helicobacter Pylori Eradication Therapy in Portugal: Prospective, Randomized, Blind and Multicentre Trial on the Efficacy of Quadruple Therapies and Their Clinical Impact, and Immunological and Gut Microbiota Changes[NCT05449028] | 230 participants (Anticipated) | Interventional | 2022-05-01 | Recruiting | |||
| Rifaximin Associated With Classic Triple Therapy (Inhibitor of Proton Pump, Amoxicillin and Clarithromycin) for the Eradication of Helicobacter Pylori Infection[NCT03124199] | Phase 3 | 40 participants (Actual) | Interventional | 2014-02-28 | Completed | ||
| The Phase 2 Study of FP-10, the Food Ingredient Derived From Milk Casein, on the Eradication Rates of Helicobacter Pylori by a Triple Therapy With Lansoprazole, Amoxicillin, and Clarithromycin[NCT00281047] | Phase 2/Phase 3 | 138 participants | Interventional | 2006-01-31 | Recruiting | ||
| Phase 4, Prospective, Randomized and Comparative Study Comparing Sequential and Concomitant Therapy for Helicobacter Pylori Eradication in Routine Clinical Practice[NCT01273441] | Phase 4 | 338 participants (Actual) | Interventional | 2010-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Percentage of patients that has comply with treatment, considered as intake of more than 90% of study drugs in patients who attended the post-treatment visit. (NCT03124199)
Timeframe: 1 month
| Intervention | percentage of participants (Number) |
|---|---|
| Rifaximin | 100 |
Percentage of Participants with H.Pylori Infection Eradication confirmed with urea breath test at least 4 weeks after the end of treatment (NCT03124199)
Timeframe: 1 month
| Intervention | percentage of participants (Number) |
|---|---|
| Rifaximin | 61 |
Patients with side effects present during treatment and in the 4 weeks after end of treatment (NCT03124199)
Timeframe: 1 month
| Intervention | participants (Number) | ||||
|---|---|---|---|---|---|
| with diarrhea | with metallic taste | headache | nausea | abdominal pain | |
| Rifaximin | 13 | 9 | 5 | 5 | 1 |
12 reviews available for metronidazole and Dyspepsia
| Article | Year |
|---|---|
Helicobacter pylori: A Review of Current Diagnostic and Management Strategies.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Biopsy; Bismuth; Breath | 2020 |
Diagnosis and treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Antidiarrheals; Bismuth; Clarithromycin; Denmark; Drug Therapy, | 2011 |
[Helicobacter pylori. Update 2002].
Topics: Adenocarcinoma; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Duode | 2002 |
[Guidelines for the diagnosis and treatment of H. pylori infection].
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Drug Therapy, Combination; Duodenal Ulcer; Dysp | 2003 |
Role of Helicobacter pylori in functional dyspepsia.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Breath Tests; Clarithromycin; Dose-Response Relationsh | 2006 |
Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Administration Schedule; Drug Therapy, Combination; Dyspeps | 2007 |
[Functional dyspepsia: approaches to Helicobacter pylori eradication therapy].
Topics: Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyspepsia; Gastritis | 1995 |
Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology.
Topics: Antacids; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Biopsy; | 1996 |
Triple therapy and Helicobacter pylori.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; | 1996 |
Review: Helicobacter pylori. Current issues and new directions.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bismuth; Drug Therapy, Combination; | 1997 |
Helicobacter pylori: a clinical update.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combinat | 2001 |
Review article: the treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Gastritis; Hel | 1992 |
76 trials available for metronidazole and Dyspepsia
| Article | Year |
|---|---|
[Is sequential eradication of Helicobacter pylori effective? Sequential treatment more effective than triple therapy in patients with clarithromycin resistance].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clar | 2013 |
Effectiveness of sequential v. standard triple therapy for treatment of Helicobacter pylori infection in children in Nairobi, Kenya.
Topics: Abdominal Pain; Adolescent; Amoxicillin; Anti-Bacterial Agents; Biopsy; Child; Child, Preschool; Cla | 2013 |
Helicobacter pylori eradication in renal recipient: triple or quadruple therapy?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Breath Tests; Drug Therapy, Combination; | 2014 |
Randomized clinical trial comparing 10-day sequential, 7-day concomitant and 7-day standard triple therapies for Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Sch | 2016 |
Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy; Breath Tests; Carbon Isotopes; Clarithromyc | 2016 |
Rescue Therapy for Helicobacter pylori Eradication: A Randomized Non-Inferiority Trial of Amoxicillin or Tetracycline in Bismuth Quadruple Therapy.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Drug Resistance, Bacterial; Drug | 2016 |
Efficacy of quadruple therapy with pantoprazole, bismuth, tetracycline and metronidazole as rescue treatment for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Benz | 2002 |
Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Breath Tests; Chronic Disease; Drug T | 2002 |
Does Helicobacter pylori eradication affect symptoms in nonulcer dyspepsia: a 5-year follow-up study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Therapy, Combination; Dyspep | 2002 |
The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance; Drug Therapy, Combi | 2002 |
One-week ranitidine bismuth citrate, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combinati | 2002 |
Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second-line Helicobacter pylori eradication in Japan, and the influence of metronidazole resistance.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer | 2003 |
Effect of treatment of Helicobacter pylori on the prevention of gastroduodenal ulcers in patients receiving long-term NSAIDs: a double-blind, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Cl | 2003 |
Increased reflux symptoms after calcium carbonate supplementation and successful anti-Helicobacter pylori treatment.
Topics: Adult; Amoxicillin; Antacids; Bismuth; Calcium Carbonate; Drug Therapy, Combination; Dyspepsia; Fema | 2003 |
Salvage therapy after two or more prior Helicobacter pylori treatment failures: the super salvage regimen.
Topics: Adult; Antacids; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Breath Te | 2003 |
One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; B | 2003 |
Comparable Helicobacter pylori eradication rates obtained with 4- and 7-day rabeprazole-based triple therapy: a preliminary study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Ag | 2003 |
Economic evaluation of Helicobacter pylori eradication in the CADET-Hp randomized controlled trial of H. pylori-positive primary care patients with uninvestigated dyspepsia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithrom | 2004 |
Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cost Savings; Cost-Ben | 2003 |
Does the 'test-and-treat' strategy work in primary health care for management of uninvestigated dyspepsia? A prospective two-year follow-up study of 1552 patients.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Dyspepsia; Endoscopy, Gastrointestinal | 2004 |
Eradication rate of Helicobacter pylori in dyspeptic patients.
Topics: Analysis of Variance; Anti-Bacterial Agents; Breath Tests; Ciprofloxacin; Drug Therapy, Combination; | 2005 |
Low-dose rabeprazole, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; An | 2005 |
Comparison of the efficacy of 1-day high-dose quadruple therapy versus 7-day triple therapy for treatment of Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Clarithromycin; | 2005 |
Twice-a-day quadruple therapy for eradication of Helicobacter pylori in the elderly.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Breath Tests; Dyspepsia; Esomeprazole; Female; Helic | 2006 |
Bismuth-based therapies for the first step eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Antacids; Anti-Infect | 2006 |
Does delayed gastric emptying shorten the H pylori eradication period? A double blind clinical trial.
Topics: Antacids; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Dopamine Agents; | 2006 |
Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Infective Agents; Dyspepsia; Femal | 2008 |
The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer | 2007 |
Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents | 2008 |
Effect of a community screening for Helicobacter pylori: a 5-Yr follow-up study.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Community Health Services; Cost-Benefit Analy | 2008 |
Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori.
Topics: Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Famotidine; F | 1995 |
[Comparison of 2 treatment schemes to eradicate Helicobacter pylori].
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Dyspepsia; Endosco | 1995 |
[Short-term triple therapy with pantoprazole, clarithromycin and metronidazole in eradication of Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimid | 1995 |
Long-term follow-up of Helicobacter pylori treatment in non-ulcer dyspepsia patients.
Topics: Adult; Bismuth; Drug Therapy, Combination; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infect | 1995 |
Long-term prospective study of Helicobacter pylori in nonulcer dyspepsia.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Drug Administration Schedule; Drug Therapy, Combina | 1995 |
One-week low-dose triple therapy for the eradication of Helicobacter pylori infection.
Topics: Adult; Aged; Aged, 80 and over; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combinat | 1995 |
Evaluation of two therapeutic regimens for the treatment of Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combinat | 1994 |
Efficacy and side effects of a triple drug regimen for the eradication of Helicobacter pylori.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Administration Schedule; Drug Therapy, C | 1993 |
Are routine duodenal and antral biopsies useful in the management of "functional" dyspepsia? A diagnostic and therapeutic study.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Bismuth; Cisapride; Double-Blind Method; Du | 1993 |
Triple therapy with ranitidine, clarithromycin, and metronidazole in the treatment of Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Interactions; Drug Thera | 1995 |
Long-term outcome of triple therapy in Helicobacter pylori-related nonulcer dyspepsia: a prospective controlled assessment.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Antibodies, Bacterial; Chronic Disease; Drug Th | 1996 |
Eradication of Helicobacter pylori and long-term outcome of functional dyspepsia. A clinical endoscopic study.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; | 1996 |
Only four days of quadruple therapy can effectively cure Helicobacter pylori infection.
Topics: Adult; Aged; Aged, 80 and over; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Th | 1995 |
Long-term follow-up after cure of Helicobacter pylori infection with 4 days of quadruple therapy.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Dyspepsia; Heli | 1996 |
One-day intensified lansoprazole-quadruple therapy for cure of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti | 1997 |
Eradication of Helicobacter pylori affects symptoms in non-ulcer dyspepsia.
Topics: Adult; Anti-Bacterial Agents; Bismuth; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Fe | 1997 |
Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Anti-Bacterial Agents; Anti-Ulcer Agents; B | 1997 |
Pantoprazole versus omeprazole in one-week low-dose triple therapy for curve of H. pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; C | 1997 |
Effectiveness of quadruple therapy using lansoprazole, instead of omeprazole, in curing Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Antacids; Anti-Ulcer Agents; Bacterial Protein | 1996 |
[Endocrine and exocrine gastric mucosal secretion in the course of H. pylori eradication in patients with non-ulcer dyspepsia].
Topics: Amoxicillin; Bismuth; Dyspepsia; Epidermal Growth Factor; Gastric Juice; Gastric Mucosa; Gastrins; H | 1997 |
Four-day lansoprazole-quadruple therapy in the routine treatment of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Drug Administration Sch | 1998 |
Cure of H. pylori infection using a 7-day triple therapy combining pantoprazole with two antibiotics.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents | 1998 |
A new quadruple therapy for the eradication of Helicobacter pylori. Effect of pretreatment with omeprazole on the cure rate.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Dyspe | 1998 |
Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combin | 1998 |
Randomized controlled comparison of nitroimidazoles for the eradication of Helicobacter pylori and relief of ulcer-associated and non-ulcer dyspepsia.
Topics: Adult; Aged; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Dyspeps | 1999 |
Helicobacter pylori-positive functional dyspepsia in elderly patients: comparison of two treatments.
Topics: Aged; Aged, 80 and over; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; D | 1999 |
Role of anti-Helicobacter pylori treatment in H. pylori-positive and cytoprotective drugs in H. pylori-negative, non-ulcer dyspepsia: results of a randomized, double-blind, controlled trial in Asian Indians.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Double-Blind Method; Drug Therapy, Combinat | 1999 |
One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: the RBC-MACH study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromy | 1999 |
Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Co | 1999 |
Helicobacter pylori and its eradication in rosacea.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dy | 1999 |
Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Diagnosis, Differential; Dose- | 2000 |
Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Ulcer Agents; Clarithr | 2001 |
Ranitidine bismuth citrate or omeprazole-based triple therapy for Helicobacter pylori eradication in Helicobacter pylori-infected non-ulcer dyspepsia.
Topics: Adult; Amoxicillin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Co | 2001 |
Eradication of Helicobacter pylori infection in patients with duodenal ulcer and non-ulcer dyspepsia and analysis of one-year reinfection rates.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duoden | 2001 |
Fish oil (Eicosapen) is less effective than metronidazole, in combination with pantoprazole and clarithromycin, for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Benz | 2001 |
Ranitidine bismuth citrate with clarithromycin alone or with metronidazole for the eradication of Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Carbon Isotopes; Clari | 2001 |
A randomized comparison of four omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia.
Topics: Administration, Oral; Adult; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Azit | 2001 |
Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Dyspepsia; Female; H | 2001 |
Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Combinatio | 2001 |
Low-dose lansoprazole and clarithromycin plus metronidazole vs. full-dose lansoprazole and clarithromycin plus amoxicillin for eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Amoxicillin; Anti-Bacter | 2002 |
Effectiveness of two quadruple, tetracycline- or clarithromycin-containing, second-line, Helicobacter pylori eradication therapies.
Topics: Adolescent; Adult; Aged; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Interactions | 2002 |
Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Breath Tests; Canada; Clarithromy | 2002 |
Short report: omeprazole plus antibiotic combinations for the eradication of metronidazole-resistant Helicobacter pylori.
Topics: Adult; Aged; Bismuth; Circadian Rhythm; Drug Administration Schedule; Drug Resistance, Microbial; Dr | 1992 |
Eradicating Helicobacter pylori and symptoms of non-ulcer dyspepsia.
Topics: Adult; Aged; Amoxicillin; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsi | 1991 |
Triple therapy for Helicobacter pylori in nonulcer dyspepsia.
Topics: Adult; Amoxicillin; Drug Therapy, Combination; Dyspepsia; Female; Gastritis; Helicobacter Infections | 1991 |
Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication.
Topics: Administration, Oral; Adult; Aged; Campylobacter Infections; Clinical Trials as Topic; Drug Administ | 1989 |
63 other studies available for metronidazole and Dyspepsia
| Article | Year |
|---|---|
[Helicobacter pylori infection in the HIV + population: a comorbidity to think about].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Ulcer Agents; Clarithromycin; Comor | 2020 |
What is the impact of Helicobacter pylori density on the success of eradication therapy: a clinico-histopathological study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Breath Tests; Case-Control Studies; Cla | 2013 |
Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antigens, Bac | 2015 |
In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Child; C | 2016 |
[10-day triple therapy with esomeprazole 40 mg/12 h vs. quadruple concomitant non-bismuth therapy as first line treatment for Helicobacter pylori infection].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug | 2016 |
A search for Helicobacter pyloriin localized vulvodynia.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Dysp | 2008 |
Antibiotic susceptibility patterns in Helicobacter pylori strains from patients with upper gastrointestinal pathology in western Nigeria.
Topics: Amoxicillin; Anti-Bacterial Agents; Biopsy; Ciprofloxacin; Clarithromycin; DNA, Bacterial; Drug Resi | 2009 |
Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome.
Topics: Anti-Bacterial Agents; Case-Control Studies; Clarithromycin; Drug Resistance, Microbial; Dyspepsia; | 2010 |
Helicobacter pylori: prevalence and antibiotic susceptibility among Kenyans.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Black People; Child; Clarithromycin; Cohort Studies; Drug | 2010 |
Antibiotic susceptibility patterns of Helicobacter pylori and triple therapy in a high-prevalence area.
Topics: Adolescent; Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resis | 2010 |
CagA genotype and metronidazole resistant strain of Helicobacter pylori in functional dyspepsia in Thailand.
Topics: Abdominal Pain; Anti-Infective Agents; Antigens, Bacterial; Bacterial Proteins; Biopsy; Drug Resista | 2011 |
Is Helicobacter pylori antibiotic resistance surveillance needed and how can it be delivered?
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Dyspepsia; Endoscopy; England; Fe | 2012 |
High prevalence of primary antibiotic resistance in Helicobacter pylori isolates in Italy.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; D | 2012 |
Quantification of Helicobacter pylori resistance in functional and organic dyspepsia.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Cohort Studies; Drug | 2002 |
[Association among anti-CagA antibody detection, antibiotic susceptibility, and peptic ulcer in patients with Helicobacter pylori infection].
Topics: Adult; Aged; Antibodies, Bacterial; Antibody Specificity; Antigens, Bacterial; Bacterial Proteins; C | 2003 |
Metronidazole-resistant Helicobacter pylori is more prevalent in patients with nonulcer dyspepsia than in peptic ulcer patients in a multiethnic Asian population.
Topics: Asian People; Biopsy; Drug Resistance, Bacterial; Dyspepsia; Ethnicity; Female; Helicobacter Infecti | 2003 |
Helicobacter pylori: antibiotic resistance and eradication rates in Suffolk, UK, 1991-2001.
Topics: Adult; Age Factors; Amoxicillin; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combinati | 2004 |
Recurrence of Helicobacter pylori infection 1 year after successful treatment: prospective cohort study in the Republic of Yemen.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Chronic Disease; Clarithromyc | 2004 |
Standard treatment for Helicobacter pylori infection is suboptimal in non-ulcer dyspepsia compared with duodenal ulcer in Chinese.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Asian People; Clarithromycin; Drug Resistan | 2005 |
Helicobacter pylori infection in Greenlandic patients with dyspepsia.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Dyspepsia; Esomeprazole; Greenland; Helicobac | 2004 |
Helicobacter pylori antibiotic-resistance patterns and risk factors in adult dyspeptic patients from ethnically diverse populations in central and south London during 2000.
Topics: Adult; Aged; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Clarithromycin; Drug Re | 2005 |
Helicobacter pylori antibiotic resistance in a Dutch region: trends over time.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Resistance, Bacteria | 2006 |
Guidelines in the medical treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Dyspeps | 2006 |
Antimicrobial effectiveness of ketoconazole against metronidazole-resistant Helicobacter pylori isolates from Iranian dyspeptic patients.
Topics: Drug Resistance, Bacterial; Dyspepsia; Helicobacter pylori; Humans; Ketoconazole; Metronidazole | 2007 |
Patterns of Helicobacter pylori isolate resistance to fluoroquinolones, amoxicillin, clarithromycin and metronidazoles.
Topics: Amoxicillin; Anti-Bacterial Agents; Biopsy; Chronic Disease; Clarithromycin; Disk Diffusion Antimicr | 2006 |
Helicobacter pylori culture and antimicrobial resistance in Iran.
Topics: Adolescent; Anti-Bacterial Agents; Biopsy, Needle; Child; Child, Preschool; Drug Resistance, Bacteri | 2007 |
Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Dysp | 2007 |
Helicobacter pylori isolates recovered from gastric biopsies of patients with gastro-duodenal pathologies in Cameroon: current status of antibiogram.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy; Cameroon; Clarithromycin; Drug | 2008 |
[Omeprazole + clarithromycin + metronidazole--a new standard for eradication of Helicobacter pylori].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin | 1995 |
Prevalence of metronidazole-resistant Helicobacter pylori in dyspeptic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Drug Resistance, Microbial; Dyspepsia; Female; He | 1993 |
Metronidazole affects Helicobacter pylori related nonulcer dyspepsia and symptoms from carbohydrate malabsorption.
Topics: Anti-Bacterial Agents; Dyspepsia; Fructose; Helicobacter Infections; Helicobacter pylori; Humans; Ma | 1995 |
Azithromycin for the cure of Helicobacter pylori infection.
Topics: Adult; Aged; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Drug Therapy, Combina | 1996 |
Helicobacter pylori reinfection after apparent eradication--the Ipswich experience.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Case-Control Studies; Drug T | 1996 |
Dysfunction in gastric myoelectric and motor activity in Helicobacter pylori positive gastritis patients with non-ulcer dyspesia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithrom | 1996 |
Endoscopic topical therapy for the treatment of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Topical; Amoxicillin; Antacids; Anti-Ulcer | 1996 |
[Good results with Helicobacter pylori eradication for treatment of non-ulcer dyspepsia].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; D | 1996 |
Clarithromycin resistance in Helicobacter pylori: prevalence in untreated dyspeptic patients and stability in vitro.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Dyspepsia; Erythromycin; F | 1996 |
Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; D | 1997 |
One-day high-dose combined therapy of Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Drug Evaluation; Drug Therapy, Combination; | 1997 |
Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Breath T | 1998 |
Four-day quadruple therapy as a routine treatment for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer | 1997 |
Metronidazole- and clarithromycin-resistant Helicobacter pylori in dyspeptic patients in western Sydney as determined by testing multiple isolates from different gastric sites.
Topics: Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Clarithromycin; Drug Resistance, Microbial | 1998 |
Prevalence and demographic determinants of metronidazole resistance by Helicobacter pylori in a large cosmopolitan cohort of Australian dyspeptic patients.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Asia, Southeastern; Australia; Drug Resistance, Microbial; | 1998 |
[Treatment of Helicobacter pylori infection].
Topics: Antacids; Anti-Bacterial Agents; Clarithromycin; Dyspepsia; Gastroesophageal Reflux; Helicobacter In | 1998 |
[Symptomatic improvement of patients with nonulcer dyspepsia after Helicobacter pylori eradication].
Topics: Amoxicillin; Anti-Ulcer Agents; Breath Tests; Drug Therapy, Combination; Dyspepsia; Helicobacter Inf | 1999 |
Is there any difference in Helicobacter pylori eradication rates in patients with active peptic ulcer, inactive peptic ulcer and functional dyspepsia?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dy | 1999 |
Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Brazil; Drug Resistance, Microbial; Dru | 2000 |
[IgG and IgA immunoglobulins in helicobacter pylori infections of children with chronic dyspepsia before and after two week triple drug therapy].
Topics: Adolescent; Amoxicillin; Bismuth; Blotting, Western; Child; Chronic Disease; Drug Therapy, Combinati | 1999 |
Amplified fragment length polymorphism genotyping of metronidazole-resistant Helicobacter pylori infecting dyspeptics in England.
Topics: Anti-Bacterial Agents; Cluster Analysis; Deoxyribonuclease HindIII; DNA, Bacterial; Drug Resistance, | 2001 |
In search of the Holy Grail of Heliocobacter pylori remedies.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Clarithromyci | 2001 |
Strategy for retreatment of therapeutic failure of eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agent | 2001 |
Clarithromycin resistance of Helicobacter pylori has a major impact on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Biopsy; Clarithromycin; DNA, Bacterial; Dru | 2001 |
The role of treatment with proton pump inhibitors and anti-Helicobacter therapy in functional dyspepsia.
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Helicob | 2001 |
[Dyspepsia and Helicobacter pylori infection in employees of a large industry. Results of a prospective BASF Helicobacter pylori prevention campaign].
Topics: Adolescent; Adult; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Gastritis; Germany; | 2002 |
Prevalence of H. pylori-infection in family members of H. pylori positive and its influence on the reinfection rate after successful eradication therapy: a two-year follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Breath Tests; Child; Child, Preschool; Clarithromycin; D | 2002 |
Eradicating Helicobacter pylori.
Topics: Amoxicillin; Bismuth; Drug Resistance, Microbial; Drug Therapy, Combination; Dyspepsia; Helicobacter | 1992 |
Clinicopathological assessment of gastric biopsy samples of patients with Helicobacter pylori infection--metronidazole resistance and compliance problems in the United Arab Emirates.
Topics: Adolescent; Adult; Antacids; Bacteriological Techniques; Bismuth; Doxycycline; Drug Resistance, Micr | 1992 |
The role of Helicobacter pylori in the pathogenesis of acid-peptic disease.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Black or African American; Dyspepsia; Gastritis; Helicobac | 1992 |
Does a previous course of tripotassium dicitrato bismuthate affect the subsequent chances of successful Helicobacter pylori eradication?
Topics: Adult; Aged; Drug Administration Schedule; Drug Resistance, Microbial; Duodenal Ulcer; Dyspepsia; Fe | 1992 |
[Helicobacter pylori: from harmless commensal to clinically significant disease factor].
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Gastritis; Helicobacter | 1992 |
Helicobacter pylori and non-ulcer dyspepsia.
Topics: Colloids; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans | 1992 |
Metronidazole in acid peptic disease.
Topics: Amebiasis; Antacids; Campylobacter Infections; Drug Therapy, Combination; Dyspepsia; Humans; Metroni | 1990 |
Campylobacter pylori in patients with dyspeptic symptoms and endoscopic evidence of erosion(s).
Topics: Adolescent; Adult; Aged; Bismuth; Campylobacter; Duodenitis; Dyspepsia; Endoscopy; Gastric Mucosa; G | 1989 |